LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Abeona Therapeutics and Millions of Other Companies

Sign up for full access to Abeona Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Gene Therapy Development Abeona Therapeutics is actively developing gene therapies for serious diseases, such as epidermolysis bullosa and ophthalmic diseases. This focus on innovative treatments presents potential sales opportunities for partnerships with healthcare providers and institutions seeking advanced therapeutic solutions.

Board Expansion Recent appointments of experienced medical professionals, such as Eric Crombez and Bernhardt G. Zeiher, to Abeona's Board of Directors indicate a strategic growth direction. Leveraging these new insights and connections could open doors for collaborations with institutions and organizations linked to the newly appointed members.

Partnership with Beacon Therapeutics The partnership with Beacon Therapeutics to explore the use of Abeona's AAV204 capsid in gene therapies for ophthalmology indicates a focus on expanding the application of their technology. This collaboration presents sales opportunities for joint research initiatives and co-development projects in the ophthalmology sector.

Regulatory Update Launch The recent regulatory update for prademagene zamikeracel showcases Abeona's commitment to advancing its therapeutic offerings. Sales professionals can leverage this update to engage with regulatory bodies, healthcare institutions, and investors interested in cutting-edge gene therapies for various medical conditions.

Credit Facility Secured Securing a $50M credit facility highlights Abeona's financial stability and growth potential. Sales development representatives can capitalize on this financial backing to negotiate favorable terms for partnerships, investments, and collaborations with stakeholders looking to align with a financially secure biotechnology company.

Similar companies to Abeona Therapeutics

✕

Access Insights for Abeona Therapeutics and Millions of Other Companies

Sign up for full access to Abeona Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Abeona Therapeutics Tech Stack

Abeona Therapeutics uses 8 technology products and services including JazzHR, WordPress, Twitter Emoji (Twemoji), and more. Explore Abeona Therapeutics's tech stack below.

  • JazzHR
    Applicant Tracking Systems
  • WordPress
    Content Management System
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Raphael
    Javascript Graphics
  • Office 365
    Office Suites
  • Bootstrap
    UI Frameworks
  • ZURB Foundation
    UI Frameworks
  • Apache
    Web Servers

Media & News

Abeona Therapeutics's Email Address Formats

Abeona Therapeutics uses at least 1 format(s):
Abeona Therapeutics Email FormatsExamplePercentage
FLast@abeonatherapeutics.comJDoe@abeonatherapeutics.com
95%
First.Last@abeonatherapeutics.comJohn.Doe@abeonatherapeutics.com
3%
Last@abeonatherapeutics.comDoe@abeonatherapeutics.com
1%
FirstLast@abeonatherapeutics.comJohnDoe@abeonatherapeutics.com
1%

Frequently Asked Questions

Where is Abeona Therapeutics's headquarters located?

Minus sign iconPlus sign iconAbeona Therapeutics's main headquarters is located at 1330 Avenue of the Americas 33rd Floor New York, NY 10019 US. The company has employees across 6 continents, including North AmericaAfricaEurope.

What is Abeona Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Abeona Therapeutics's main corporate office by phone at
✕

Access Insights for Abeona Therapeutics and Millions of Other Companies

Sign up for full access to Abeona Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-214-905-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Abeona Therapeutics's stock symbol?

Minus sign iconPlus sign iconAbeona Therapeutics is a publicly traded company; the company's stock symbol is ABEO.

What is Abeona Therapeutics's official website and social media links?

Minus sign iconPlus sign iconAbeona Therapeutics's official website is abeonatherapeutics.com and has social profiles on LinkedIn.

How much revenue does Abeona Therapeutics generate?

Minus sign iconPlus sign icon As of September 2024, Abeona Therapeutics's annual revenue reached $35M.

What is Abeona Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconAbeona Therapeutics's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abeona Therapeutics have currently?

Minus sign iconPlus sign iconAs of September 2024, Abeona Therapeutics has approximately 122 employees across 6 continents, including North AmericaAfricaEurope. Key team members include Chief People Officer: A. H.Chief Financial Officer: H. W.Chief Technical Officer: J. B.. Explore Abeona Therapeutics's employee directory with LeadIQ.

What industry does Abeona Therapeutics belong to?

Minus sign iconPlus sign iconAbeona Therapeutics operates in the Biotechnology Research industry.

What technology does Abeona Therapeutics use?

Minus sign iconPlus sign iconAbeona Therapeutics's tech stack includes JazzHRWordPressTwitter Emoji (Twemoji)RaphaelOffice 365BootstrapZURB FoundationApache.

What is Abeona Therapeutics's email format?

Minus sign iconPlus sign iconAbeona Therapeutics's email format typically follows the pattern of . Find more Abeona Therapeutics email formats with LeadIQ.

How much funding has Abeona Therapeutics raised to date?

Minus sign iconPlus sign icon As of September 2024, Abeona Therapeutics has raised $75M in funding. The last funding round occurred on May 03, 2024 for $75M.

When was Abeona Therapeutics founded?

Minus sign iconPlus sign iconAbeona Therapeutics was founded in 2015.
Abeona Therapeutics

Abeona Therapeutics

Biotechnology ResearchNew York, United States51-200 Employees

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene zamikeracel (pz-cel) is Abeona’s investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa. The Company’s fully integrated cell and gene therapy cGMP manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITAL™ trial, and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases.

✕

Access Insights for Abeona Therapeutics and Millions of Other Companies

Sign up for full access to Abeona Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
1330 Avenue of the Americas 33rd Floor New York, NY 10019 US
Phone number
✕

Access Insights for Abeona Therapeutics and Millions of Other Companies

Sign up for full access to Abeona Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-214-905-****
Website
abeonatherapeutics.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ABEO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $75M

    Abeona Therapeutics has raised a total of $75M of funding over 13 rounds. Their latest funding round was raised on May 03, 2024 in the amount of $75M.

  • $10M$50M

    Abeona Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $75M

    Abeona Therapeutics has raised a total of $75M of funding over 13 rounds. Their latest funding round was raised on May 03, 2024 in the amount of $75M.

  • $10M$50M

    Abeona Therapeutics's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Abeona Therapeutics and Millions of Other Companies

Sign up for full access to Abeona Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.